doxorubicin hydrochloride has been researched along with Osteogenic Sarcoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buondonno, I; Chegaev, K; Cortese, D; Fanelli, M; Fruttero, R; Gasco, A; Gazzano, E; Ghigo, D; Hattinger, CM; Lazzarato, L; Riganti, C; Rolando, B; Serra, M | 1 |
1 other study(ies) available for doxorubicin hydrochloride and Osteogenic Sarcoma
Article | Year |
---|---|
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Hydrogen Sulfide; Molecular Structure; Myocytes, Cardiac; Osteosarcoma; Reactive Oxygen Species; Structure-Activity Relationship | 2016 |